Gi Jung Im Selected Research

Ototoxicity

12/2016	Comparison of the effects of lipoic acid and glutathione against cisplatin-induced ototoxicity in auditory cells.
7/2016	The effects of the antioxidant α-tocopherol succinate on cisplatin-induced ototoxicity in HEI-OC1 auditory cells.
1/2016	Sodium Selenite Acts as an Otoprotectant against Neomycin-Induced Hair Cell Damage in a Zebrafish Model.
12/2015	Protective role of edaravone against cisplatin-induced ototoxicity in an auditory cell line.
7/2015	Response to the Letter to the Editor regarding "Protective effect of resveratrol against cisplatin-induced ototoxicity in HEI-OC1 auditory cells".
1/2015	Protective effect of resveratrol against cisplatin-induced ototoxicity in HEI-OC1 auditory cells.
8/2014	Protective effects of caffeic acid phenethyl ester (CAPE) against neomycin-induced hair cell damage in zebrafish.
5/2014	Protective role of edaravone against neomycin-induced ototoxicity in zebrafish.
4/2014	Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line.
2/2014	Protective role of NecroX-5 against neomycin-induced hair cell damage in zebrafish.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gi Jung Im Research Topics

Disease

21	Ototoxicity 12/2016 - 05/2007
4	Tinnitus 01/2021 - 05/2007
3	Sensorineural Hearing Loss 03/2021 - 04/2010
3	Hearing Loss (Hearing Impairment) 07/2016 - 05/2007
2	Otitis Media 10/2016 - 01/2015
2	Inflammation (Inflammations) 10/2016 - 05/2014
2	Infections 12/2015 - 01/2015
2	Cholesteatoma 02/2013 - 02/2012
1	Dizziness (Lightheadedness) 09/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2021
1	Hidden Hearing Loss 01/2021
1	Necrosis 07/2016
1	Deafness (Deaf Mutism) 05/2014
1	Otosclerosis 10/2011
1	Nasal Obstruction 05/2008

Drug/Important Bio-Agent (IBA)

10	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 04/2010
5	Neomycin FDA LinkGeneric 01/2016 - 12/2013
4	Proteins (Proteins, Gene)FDA Link 10/2012 - 03/2009
4	SalicylatesIBA 09/2010 - 05/2007
3	Metformin (Glucophage)FDA LinkGeneric 10/2016 - 12/2011
3	Pharmaceutical PreparationsIBA 09/2016 - 10/2012
3	EdaravoneIBA 12/2015 - 06/2013
3	CalciumIBA 04/2014 - 12/2011
2	SteroidsIBA 01/2021 - 06/2012
2	ResveratrolIBA 07/2015 - 01/2015
2	Free RadicalsIBA 08/2014 - 05/2014
2	Messenger RNA (mRNA)IBA 02/2013 - 09/2010
2	Gentamicins (Gentamicin)FDA LinkGeneric 12/2011 - 12/2011
2	DNA (Deoxyribonucleic Acid)IBA 09/2009 - 05/2007
1	SolutionsIBA 09/2021
1	Thioctic Acid (Lipoic Acid)IBA 12/2016
1	Glutathione (Reduced Glutathione)IBA 12/2016
1	LipopolysaccharidesIBA 10/2016
1	tianeptine (Stablon)IBA 09/2016
1	AntioxidantsIBA 07/2016
1	acivicin (AT 125)IBA 07/2016
1	alpha-Tocopherol FDA Link 07/2016
1	Tocopherols (Tocopherol)IBA 07/2016
1	Sodium SeleniteIBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	EugenolIBA 01/2015
1	AminoglycosidesIBA 08/2014
1	caffeic acid phenethyl esterIBA 08/2014
1	Oxygen (Dioxygen)IBA 08/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2014
1	Neuroprotective AgentsIBA 05/2014
1	NecroX-5IBA 02/2014
1	acetovanillone (apocynin)IBA 02/2013
1	rac1 GTP-Binding ProteinIBA 02/2013
1	Acetic Acid (Vinegar)FDA LinkGeneric 02/2012
1	Insulin-Like PeptidesIBA 09/2010
1	Antineoplastic Agents (Antineoplastics)IBA 04/2010
1	A-Form DNA (A-DNA)IBA 05/2008
1	OligonucleotidesIBA 05/2007

Therapy/Procedure

1	Glycemic Control 03/2021
1	Cochlear Implants (Cochlear Implant) 12/2015
1	Therapeutics 02/2012
1	Debridement 02/2012
1	Ossicular Prosthesis (TORP) 10/2011
1	Cautery 05/2008